Showing results (81-90 of 342) with videos related to
Sort By:
Pageof 35
Therapeutic Drug Monitoring|December 1, 1993
Alternative approaches for Phase I studies of anticancer drugs: a role for therapeutic drug monitoringW E EvansLeukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Sex differences in prognosis for children with acute lymphoblastic leukemiaC H Pui, J M Boyett, M V Relling, et al.The New England Journal of Medicine|June 19, 1997
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemiaC H Pui, J M Boyett, W T Hughes, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Human cytochrome P450 metabolism of teniposide and etoposideM V Relling, R Evans, C Dass, et al.Leukemia|February 13, 2002
Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurineT Dervieux, M Hancock, W Evans, et al.The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differencesJ A Johnson, V L Herring, M S Wolfe, et al.Clinical Pharmacology and Therapeutics|November 1, 1994
Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatinM V Relling, H L McLeod, L C Bowman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humansE G Schuetz, A H Schinkel, M V Relling, et al.Pageof 35